-
October 7, 2025
Safety
New
MHLW Pharmaceuticals and Medical Devices Safety Information No.423 posted
-
September 19, 2025
Safety
PMDA Risk Communications: Lubiprostone, etc. posted
-
September 18, 2025
Safety
PMDA Alert for Proper Use of Drugs: No. 7 Compliance with Measurement of Blood Lithium Levels during Treatment with Lithium Carbonate (revision) posted
-
September 17, 2025
Safety
Revisions of PRECAUTIONS: Tarlatamab (genetical recombination) posted
-
August 28, 2025
Safety
Revisions of PRECAUTIONS: Delandistrogene moxeparvovec posted
-
July 23, 2025
Safety
PMDA Risk Communications (medical devices risk information of ongoing evaluation): Cadaveric dura mater posted
-
April 18, 2025
Safety
PMDA Risk Communication: Onasemnogene abeparvovec posted
-
March 17, 2025
Safety
Notification Related to Safety Measures (Drugs): Questions and Answers (Qs & As) on the Guidance for Provision of Dear Healthcare Professional Letters of Emergent/Rapid Safety Communications posted
-
March 5, 2025
Safety
Revisions of PRECAUTIONS: Axicabtagene ciloleucel, etc. posted
-
March 5, 2025
Safety
Revisions of PRECAUTIONS: Ethical combination drugs (Brand name: Twinpal Injection), etc. posted
-
February 26, 2025
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.417 posted
-
February 5, 2025
Safety
PMDA Medical Safety Information: Cases of Air Embolism Due to the Use of Central Venous Catheters (No. 71) posted
-
January 6, 2025
Safety
Notification Related to Safety Measures (Regenerative Medical Products) : Instructions for Electronic Package Inserts of Regenerative Medical Products posted
-
December 17, 2024
Safety
Notification Related to Safety Measures (Regenerative Medical Products) : Instructions for Electronic Package Inserts of Regenerative Medical Products posted
-
October 24, 2024
Safety
Update: Publication of MIHARI project
-
April 10, 2024
Safety
Notifications Related to Safety Measures (medical devices): Questions and Answers (Q&A) on MR Safety of Implantable Medical Devices, etc. (Part 2) posted
-
March 28, 2024
Safety
Revisions of PRECAUTIONS (Regenerative Medical Products): Axicabtagene ciloleucel, etc. posted
-
March 28, 2024
Safety
Revisions of PRECAUTIONS: Andexanet alfa (genetical recombination) posted
-
March 14, 2024
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.408
-
February 29, 2024
Safety
Notifications Related to Safety Measures (in vitro diagnostics) : Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
-
December 27, 2023
Safety
English Translated Package Inserts page: Ensure Liquid updated
-
March 27, 2023
Safety
Revisions of PRECAUTIONS:Anti-human thymocyte immunoglobulin, rabbit posted
-
March 14, 2023
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.399
-
July 29, 2022
Safety
Risk Management Plan (RMP) :RMP Page renewal, Questions and Answers (Qs and As) on Risk Management Plan, Risk Management Plan templates, instructions and publication posted
-
March 23, 2022
Safety
Revisions of PRECAUTIONS: Ticagrelor, etc. posted
-
March 11, 2022
Safety
PMDA Alert for Proper Use of Medical Devices: Bleeding Caused by the Use of IMPELLA Circulatory Assistance Pump Catheter, posted
-
March 8, 2022
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.390
-
December 24, 2021
Safety
Revisions of PRECAUTIONS (Medical Devices): Power Morcellators posted
-
June 1, 2021
Safety
Urgent Safety Information (the blue letter) Joyclu, has been posted.
-
March 30, 2021
Safety
Revisions of PRECAUTIONS (Cellular and Tissue-based Products): Onasemnogene abeparvovec, posted
-
March 30, 2021
Safety
Revisions of PRECAUTIONS: Magnesium sulfate hydrate/glucose, etc. posted
-
March 23, 2021
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.381
-
February 18, 2021
Safety
Notification on self-check, posted
-
July 10, 2020
Safety
PMDA Alert for Proper Use of Medical Devices (for patients): For patients who use a ventilator, etc. at home and their families or other caregivers, posted
-
March 31, 2020
Safety
Revisions of PRECAUTIONS:Spiperone, etc. posted
-
March 24, 2020
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.371
-
March 28, 2019
Safety
Revisions of PRECAUTIONS:Amobarbital, etc. posted
-
March 12, 2019
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.361
-
March 27, 2018
Safety
Revisions of PRECAUTIONS: Adrenaline, etc. posted
-
March 14, 2018
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.351
-
March 21, 2017
Safety
Revisions of PRECAUTIONS: Lamotrigine, etc. posted
-
April 18, 2016
Safety
Investigation results: Mycophenolate Mofetil posted
-
March 24, 2016
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.331
-
June 30, 2015
Safety
Notification on Self-inspection: Electric massage devices for home use
-
May 19, 2015
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.321
-
April 8, 2015
Safety
Revisions of PRECAUTIONS (Summary of investigation results): cetuximab and panitumumab posted